Evaluation of MS-209, a novel multidrug-resistance-reversing agent, in tumour-bearing mice by technetium-99m-MIBI imaging

European Journal of Nuclear Medicine

Volumn 29, Issue 3, 2002, Pages 288-294

  Tatsumi, Mitsuaki ^a   Tsuruo, Takashi ^b   Nishimura, Tsunehiko ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

99mTc MIBI imaging; Multidrug resistance reversing agent; P glycoprotein; Tumour bearing mouse

Indexed keywords

5 [3 (4 DIPHENYLACETYL 1 PIPERAZINYL) 2 HYDROXYPROPOXY]QUINOLINE; GLYCOPROTEIN P; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; CELL LINE; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG DISTRIBUTION; DRUG EFFECT; DRUG SCREENING; FEMALE; HUMAN; HUMAN CELL; IMAGING; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; XENOGRAFT;

EID: 0036206687     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-001-0705-1     Document Type: Article

References (33)

1. Biochemistry of multidrug resistance mediated by the multidrug transporter
2. Isolation and expression of a complementary DNA that confers multidrug resistance
3. Human multidrug-resistant cell lines: Increased mdr1 expression can precede gene amplification
4. Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome
5. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil
6. Clinical studies with modulators of multidrug resistance
7. P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil
8. Modulation of multidrug-resistant multiple myeloma by cyclosporin
9. Controlled trial of dexverapamil, a modulator of multidrug resistance, in lymphomas refractory to EPOCH chemotherapy
10. In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative
11. Reversal of multidrug resistance by a novel quinoline derivative, MS-209
12. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex
13. Expression of recombinant human multidrug resistance P-glycoprotein in insect cells confers decreased accumulation of technetium-99m-sestamibi
14. m-sestamibi as an agent for imaging P-glycoprotein-mediated multidrug resistance: In vitro and in vivo studies in a rat breast tumour cell line and its doxorubicin-resistant variant
15. In vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients
16. Isolation and genetic characterization of human KB cell lines resistant to multiple drugs
17. The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein
18. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line
19. Protein kinase C isoenzymes, p53, accumulation of rhodamine 123, glutathione-S-transferase, topoisomerase II and MRP in multidrug resistant cell lines
20. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
21. Relationship between multidrug resistant gene expression and multidrug resistant-reversing effect of MS-209 in various tumor cells
22. Potentiation of the antitumor activity by a novel quinoline compound, MS-209, in multidrug-resistant solid tumor cell lines
23. Technetium-99m-furifosmin as an agent for functional imaging of multidrug resistance in tumors
24. m-sestamibi imaging of inhibition of the multidrug resistance transporter in a mouse xenograft model of human breast cancer
25. Characterization of P-glycoprotein transport and inhibition in vivo
26. Fractional retention of technetium-99m-sestamibi as an index of P-glycoprotein expression in untreated breast cancer patients
27. Association of tumor washout rates and accumulation of technetium-99m-MIBI with expression of P-glycoprotein in lung cancer
28. Characterization of multidrug resistance P-glycoprotein transport function with an organotechnetium cation
29. 201Tl uptake in tumours
30. Structure and expression of the messenger RNA encoding the murine multidrug resistance protein, an ATP-binding cassette transporter
31. 99mTc-sestamibi is a substrate for P-glycoprotein and the multidrug resistance-associated protein
32. A novel quinoline derivative, MS-209, overcomes drug resistance of human lung cancer cells expressing the multidrug resistance-associated protein (MRP) gene
33. Classical and novel forms of multidrug resistance and the physiological functions of P-glycoproteins in mammals